TPG Biotech
North America, California, United States, San Francisco
Description
TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.
Investor Profile
TPG Biotech has made 73 investments, with 1 in the past 12 months and 30% as lead.
Stage Focus
- Series B (30%)
- Series C (25%)
- Series A (21%)
- Series D (10%)
- Private Equity (5%)
- Series Unknown (4%)
- Post Ipo Equity (1%)
- Series E (1%)
- Series F (1%)
- Series G (1%)
Country Focus
- United States (88%)
- Canada (4%)
- Israel (4%)
- Denmark (1%)
- Philippines (1%)
'%3e%3ccircle r='9'/%3e%3cg id='d'%3e%3cg id='c'%3e%3cg id='b'%3e%3cpath d='m-19 0 1.169 1.169L0 0l-17.831-1.169z'/%3e%3cpath id='a' d='m-.884.116.05.05L0 0z' transform='scale(19.2381)'/%3e%3cuse xlink:href='%23a' transform='scale(1 -1)'/%3e%3c/g%3e%3cuse xlink:href='%23b' transform='rotate(45)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='rotate(90)'/%3e%3c/g%3e%3cuse xlink:href='%23d' transform='rotate(180)'/%3e%3cg transform='translate(-2.02)'%3e%3cg id='f' transform='translate(37.962)'%3e%3cpath id='e' d='M5 0 1.618 1.176l-.073 3.58-2.163-2.854-3.427 1.037L-2 0z'/%3e%3cuse xlink:href='%23e' transform='scale(1 -1)'/%3e%3c/g%3e%3cuse xlink:href='%23f' transform='rotate(120)'/%3e%3cuse xlink:href='%23f' transform='rotate(-120)'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
- Japan (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Biopharma
- Therapeutics
- Medical Device
- Health Diagnostics
- Life Science
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
